Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Sodium-glucose co-transporter-2 inhibitors (SGLT2i) use and risk of amputation: an expert panel overview of the evidence.

Sodium-glucose co-transporter-2 inhibitors (SGLT2i) use and risk of amputation: an expert panel... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Metabolism Pubmed

Sodium-glucose co-transporter-2 inhibitors (SGLT2i) use and risk of amputation: an expert panel overview of the evidence.

Loading next page...
 
/lp/pubmed/sodium-glucose-co-transporter-2-inhibitors-sglt2i-use-and-risk-of-i53yYdYAr0

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0026-0495
DOI
10.1016/j.metabol.2019.04.008
pmid
30980838

Abstract

Journal

MetabolismPubmed

Published: Feb 7, 2020

There are no references for this article.